DK3017039T3 - Funktionalisering af endogene bakterier - Google Patents
Funktionalisering af endogene bakterier Download PDFInfo
- Publication number
- DK3017039T3 DK3017039T3 DK14819499.6T DK14819499T DK3017039T3 DK 3017039 T3 DK3017039 T3 DK 3017039T3 DK 14819499 T DK14819499 T DK 14819499T DK 3017039 T3 DK3017039 T3 DK 3017039T3
- Authority
- DK
- Denmark
- Prior art keywords
- endogene
- functionalization
- bacteria
- endogene bacteria
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title 1
- 238000007306 functionalization reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14111—Inoviridae
- C12N2795/14132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14111—Inoviridae
- C12N2795/14141—Use of virus, viral particle or viral elements as a vector
- C12N2795/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14111—Inoviridae
- C12N2795/14171—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361841904P | 2013-07-01 | 2013-07-01 | |
| PCT/US2014/045034 WO2015002939A1 (en) | 2013-07-01 | 2014-07-01 | Functionalization of endogenous bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3017039T3 true DK3017039T3 (da) | 2021-06-07 |
Family
ID=52115959
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14819499.6T DK3017039T3 (da) | 2013-07-01 | 2014-07-01 | Funktionalisering af endogene bakterier |
| DK21162822.7T DK3878952T1 (da) | 2013-07-01 | 2014-07-01 | Funktionalisering af endogene bakterier |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21162822.7T DK3878952T1 (da) | 2013-07-01 | 2014-07-01 | Funktionalisering af endogene bakterier |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US9957511B2 (da) |
| EP (3) | EP4023750A1 (da) |
| DE (1) | DE21162822T1 (da) |
| DK (2) | DK3017039T3 (da) |
| ES (1) | ES2902386T1 (da) |
| WO (1) | WO2015002939A1 (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
| US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
| EP4023750A1 (en) | 2013-07-01 | 2022-07-06 | Massachusetts Institute of Technology | Functionalization of endogenous bacteria |
| JP6755801B2 (ja) | 2014-01-29 | 2020-09-16 | シンファジェン・リミテッド・ライアビリティ・カンパニーＳｙｎＰｈａＧｅｎ ＬＬＣ． | 治療的な使用のための、核酸送達のための治療用ファージおよび方法 |
| KR102138209B1 (ko) | 2015-05-06 | 2020-07-28 | 스니프르 테크놀로지스 리미티드 | 미생물 개체군 변경 및 미생물군 변형 |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2016201174A2 (en) * | 2015-06-10 | 2016-12-15 | Massachusetts Institute Of Technology | Gene expression in bacteroides |
| EP3384016A4 (en) * | 2015-12-04 | 2019-04-24 | Massachusetts Institute of Technology | MANIPULATED PHAGEMIDES |
| GB201600075D0 (en) * | 2016-01-03 | 2016-02-17 | Glaxosmithkline Biolog Sa | Immunogenci composition |
| EP4302824A3 (en) | 2016-04-20 | 2024-03-20 | The Board of Trustees of the Leland Stanford Junior University | Compositions and methods for nucleic acid expression and protein secretion in bacteroides |
| GB201609811D0 (en) | 2016-06-05 | 2016-07-20 | Snipr Technologies Ltd | Methods, cells, systems, arrays, RNA and kits |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| WO2018112194A1 (en) | 2016-12-15 | 2018-06-21 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
| US11549115B2 (en) | 2017-04-18 | 2023-01-10 | Yale University | Compositions and methods for regulated gene expression |
| KR102122898B1 (ko) * | 2018-02-26 | 2020-06-15 | 주식회사 엠디헬스케어 | 블라우티아 속 세균 유래 나노소포 및 이의 용도 |
| US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
| CN111004732B (zh) * | 2019-03-13 | 2021-08-24 | 江南大学 | 一种能够促进胃动素分泌的凝结芽孢杆菌及其应用 |
| CN111974985B (zh) * | 2020-09-16 | 2022-03-01 | 南京大学 | 由微型磁珠为生长模板及dna框架为引导载体的纳米粒子团簇组装方法 |
| GB202209518D0 (en) | 2022-06-29 | 2022-08-10 | Snipr Biome Aps | Treating & preventing E coli infections |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| CA2329908A1 (en) | 1998-04-24 | 1999-11-04 | The Regents Of The University Of California | Targeted gene delivery to cells by filamentous bacteriophage |
| AU778737B2 (en) * | 1999-04-14 | 2004-12-16 | Musc Foundation For Research Development | Tissue-specific and pathogen-specific toxic agents and ribozymes |
| AU7572900A (en) * | 1999-08-26 | 2001-03-19 | Vion Pharmaceuticals, Inc. | Compositions and methods for delivery of an agent using attenuated salmonella containing phage |
| US20030165877A1 (en) | 1999-09-24 | 2003-09-04 | Serge Muyldermans | Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| US7179458B2 (en) | 2002-03-08 | 2007-02-20 | Osel, Inc. | Lactobacilli expressing biologically active polypeptides and uses thereof |
| EP1598364A1 (en) * | 2004-05-21 | 2005-11-23 | AGIRx Limited | Chimerical soluble hyper IL-11 receptor and use thereof |
| AU2006220772A1 (en) * | 2005-03-04 | 2006-09-14 | Verenium Corporation | Nucleic acids and proteins and methods for making and using them |
| TW200819540A (en) * | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| AU2009217622A1 (en) * | 2008-01-10 | 2009-09-03 | Massachusetts Institute Of Technology | Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof |
| WO2010075441A1 (en) | 2008-12-22 | 2010-07-01 | Trustees Of Boston University | Modular nucleic acid-based circuits for counters, binary operations, memory, and logic |
| EP2761014B1 (en) * | 2011-09-26 | 2019-07-24 | Institute for Environmental Health, Inc. | Recombinant phage and methods |
| EP4023750A1 (en) | 2013-07-01 | 2022-07-06 | Massachusetts Institute of Technology | Functionalization of endogenous bacteria |
-
2014
- 2014-07-01 EP EP22157008.8A patent/EP4023750A1/en active Pending
- 2014-07-01 ES ES21162822T patent/ES2902386T1/es active Pending
- 2014-07-01 DK DK14819499.6T patent/DK3017039T3/da active
- 2014-07-01 US US14/320,965 patent/US9957511B2/en active Active
- 2014-07-01 DK DK21162822.7T patent/DK3878952T1/da unknown
- 2014-07-01 DE DE21162822.7T patent/DE21162822T1/de active Pending
- 2014-07-01 EP EP21162822.7A patent/EP3878952B1/en active Active
- 2014-07-01 EP EP14819499.6A patent/EP3017039B1/en active Active
- 2014-07-01 WO PCT/US2014/045034 patent/WO2015002939A1/en not_active Ceased
-
2018
- 2018-03-16 US US15/924,045 patent/US10968454B2/en not_active Expired - Fee Related
-
2021
- 2021-03-01 US US17/189,113 patent/US20220033830A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP4023750A1 (en) | 2022-07-06 |
| US20220033830A1 (en) | 2022-02-03 |
| ES2902386T1 (es) | 2022-03-28 |
| EP3878952B1 (en) | 2023-09-06 |
| US9957511B2 (en) | 2018-05-01 |
| US20180305703A1 (en) | 2018-10-25 |
| DK3878952T1 (da) | 2022-03-21 |
| EP3017039A4 (en) | 2017-03-01 |
| EP3017039B1 (en) | 2021-03-17 |
| US10968454B2 (en) | 2021-04-06 |
| EP3017039A1 (en) | 2016-05-11 |
| US20150004705A1 (en) | 2015-01-01 |
| WO2015002939A1 (en) | 2015-01-08 |
| DE21162822T1 (de) | 2022-05-05 |
| EP3878952A1 (en) | 2021-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3017039T3 (da) | Funktionalisering af endogene bakterier | |
| DK2968208T3 (da) | Behandling af kataplexi | |
| DK3342773T3 (da) | Syk-hæmmere | |
| DK3613453T3 (da) | Fordamper | |
| DK2961388T3 (da) | Kombinationer af lægemidler | |
| EP2967969C0 (en) | IMPLANT | |
| DK3077047T3 (da) | Aramcholsalte | |
| DK3052081T3 (da) | Pastil | |
| DK3060460T3 (da) | Saddel | |
| DK2965026T3 (da) | Generering af slushice | |
| PT2961752T (pt) | Imidazopiridazinas substituídas | |
| DK2943561T3 (da) | Fotobioreaktor | |
| DK3027598T3 (da) | Oxoquinazolinyl-butanamidderivater | |
| DK2956698T5 (da) | Bindestrimler | |
| DK3063264T3 (da) | Tørring af mikroorganismer | |
| EP2945942A4 (en) | Voriconazole IMMUNOASSAY | |
| DK2946640T3 (da) | Langmuir-probe | |
| EP2943489A4 (en) | DEUTERATED MOMELOTINIB | |
| EP2969096A4 (en) | Bottle pressurization delivery system | |
| DE102013106534B8 (de) | Chromatographiepipettenspitze | |
| DK3054704T3 (da) | Høreapparat | |
| EP2970310A4 (en) | 5-BROMO-indirubins | |
| EP2853297A4 (en) | kendama | |
| DK3071227T3 (da) | Fiskevaccine | |
| EP2963676A4 (en) | susceptor |